SNX29 and glioblastoma: Our study revealed that low SNX29 expression was strongly associated with ICB response in various cancers, including BLCA, GBM, HNSC, LAML, LUAD, THCA, SARC, SKCM, THYM and STAD (Fig. 7A–J).